PropertyValue
?:abstract
  • From the Document: This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the Centers for Disease Control and Prevention\'s (CDC\'s) Influenza SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] (Flu SC2) Multiplex Assay Testing is to be conducted on specimens from individuals suspected of respiratory viral infection consistent with COVID-19 [coronavirus disease 2019] by a healthcare provider Symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar COVID-19 (Disease);Health--Testing;Public health surveillance;Healthcare
is ?:annotates of
?:creator
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Fact Sheet for Healthcare Providers: CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
?:type
?:who_covidence_id
  • #740854
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/6p7qw9rg>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/6p7qw9rg>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all